May 8, 2017 / 9:31 PM / 5 months ago

BRIEF-Novartis Bioventures reports 11.1 pct passive stake in Altimmune

May 8 (Reuters) - Novartis Bioventures Ltd:

* Novartis Bioventures Ltd reports 11.1 percent passive stake in Altimmune Inc as of May 4 - SEC filing Source text: (bit.ly/2pXTPB3) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below